Form 4: Invizyne Technologies Executive Reports Stock Transaction
Insider Transaction (Form 4)
Damien Alan Perriman, Chief Commercial Officer of Invizyne Technologies Inc, reported multiple transactions in common stock on August 19, 2026.
Summary
- Option exercise/conversion: acquired 19,612 Common Stock on August 19, 2026; holds 28,499 after (Direct).
- Option exercise/conversion: disposed of 19,612 Restricted Stock Unit on August 19, 2026; holds 43,147 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Damien Alan Perriman — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Option exercise/conversion | Common Stock | 19,612 | — | — | 28,499 |
| 2026-08-19 | Option exercise/conversion | Restricted Stock Unit | 19,612 | — | — | 43,147 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Option exercise/conversion (19,612 shares) |
| 2026-08-19 | Option exercise/conversion (19,612 shares) |
Keywords
insider transaction, Form 4, EXOZ, EXOZYMES INC., neutral, Damien Alan Perriman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.